Description

Boehringer Ingelheim ePRO BI1403-0008 is intended to collect patient reported outcomes relating to a clinical trial (BI Trial 1403-0008 – Brightline-1). Patients must be given accounts by a participating site in order to log in to the app.

What's New in Version 2.10.5 (18)

Alignment of visit availability windows after Week 15. Ireland and South Korea removed as countries